Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

Xarelto in the Prophylaxis of Post Surgical Venous Thromboembolism After Elective Major Orthopedic Surgery or Hip or Knee in Indian Patients

NCT01523418•Bayer

View on ClinicalTrials.gov

Summary

The primary objective of this study is to evaluate the safety of Xarelto in the prophylaxis of VTE in Indian patients undergoing elective TKR/THR

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adult patients of either sex, undergoing elective THR/TKR, in whom, Rivaroxaban is given for thromboprophylaxis
•Patients willing to give a written informed consent

Exclusion Criteria

•Patients with history of hypersensitivity to active ingredients or excipient :cellulose microcrystalline, croscarmellose sodium, lactose monohydrate, magnesium stearate, sodium lauryl sulfate

Key Dates

Start Date

October 1, 2014

Primary Completion Date

November 1, 2016

Completion Date

November 1, 2016

Last Updated

February 4, 2016

Conditions

Prophylaxis, Thromboembolism, VenousTotal Knee ReplacementTotal Hip Replacement

Interventions

Rivaroxaban (Xarelto, BAY59-7939)

DRUG

Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement.

NCT06238960

Total Hip ReplacementTelerehabilitation+1 more

View study

RECRUITINGNA

Mako Cementless TKA vs Mako Cemented TKA

NCT06929871

Total Knee ReplacementTotal Knee Replacement Surgery+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 4, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

Inclusion Criteria

Exclusion Criteria

Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement.

Mako Cementless TKA vs Mako Cemented TKA

Cold and Compression Post TKA

Effects of Fall Prevention Program on the Number of Falls Among Elderly Following Total Knee Replacement

A Study to Compare Different Ways of Steroid Administration After Total Knee Implantation

Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study